ArticleOpen forum infectious diseases2021

Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19.

Brandon J Webb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.